tiprankstipranks
Neuren Pharmaceuticals Limited (AU:NEU)
ASX:NEU
Australian Market

Neuren Pharmaceuticals Limited (NEU) Financial Statements

Compare
190 Followers

Neuren Pharmaceuticals Limited Financial Overview

Neuren Pharmaceuticals Limited's market cap is currently $1.70B. The company's EPS TTM is AU$0.921; its P/E ratio is 14.15; Neuren Pharmaceuticals Limited is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is AU$1.03. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total RevenueAU$ 231.93MAU$ 14.55MAU$ 3.20MAU$ 717.00KAU$ 495.00K
Gross ProfitAU$ 205.17MAU$ 14.54MAU$ 3.19MAU$ 711.00KAU$ 491.00K
Operating IncomeAU$ 172.49MAU$ -1.60MAU$ -11.43MAU$ -9.53MAU$ -11.57M
EBITDAAU$ 199.26MAU$ -1.59MAU$ -8.22MAU$ -8.80MAU$ -11.07M
Net IncomeAU$ 157.08MAU$ 184.00KAU$ -7.79MAU$ -9.19MAU$ -10.82M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 228.54MAU$ 40.18MAU$ 36.78MAU$ 24.19MAU$ 13.84M
Total AssetsAU$ 247.97MAU$ 43.27MAU$ 40.06MAU$ 24.95MAU$ 14.41M
Total DebtAU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00
Net DebtAU$ -17.09MAU$ -40.18MAU$ -36.78MAU$ -24.19MAU$ -13.84M
Total LiabilitiesAU$ 42.76MAU$ 1.68MAU$ 803.00KAU$ 753.00KAU$ 559.00K
Stockholders' EquityAU$ 205.21MAU$ 41.59MAU$ 39.25MAU$ 24.20MAU$ 13.85M
Cash Flow
Free Cash FlowAU$ 184.88MAU$ 3.58MAU$ -9.98MAU$ -8.08MAU$ -11.73M
Operating Cash FlowAU$ 184.93MAU$ 3.60MAU$ -9.97MAU$ -8.08MAU$ -11.72M
Investing Cash FlowAU$ -211.49MAU$ -19.00KAU$ -10.00KAU$ -6.00KAU$ -12.00K
Financing Cash FlowAU$ 3.62MAU$ -2.00KAU$ 22.18MAU$ 19.14MAU$ 1.86M
Currency in AUD

Neuren Pharmaceuticals Limited Earnings and Revenue History

Neuren Pharmaceuticals Limited Debt to Assets

Neuren Pharmaceuticals Limited Cash Flow

Neuren Pharmaceuticals Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis